Found 0 matching trials
The Efficacy of Allo-HSCT in ND HR-CBF-AML N/A For newly diagnosed high-relapse-risk core-binding-factor acute myeloid leu...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine
Learn More & Join Trial
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 PHASE2 To evaluate the outcome of a prednisolone and low dose methotrexate based p...
Show More Status
Active Not Recruiting
Location
Prince of Wales Hospital
Learn More & Join Trial
Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT. NA Elderly AML patients receiving conventional chemotherapy have poor prognosi...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1 RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, ...
Show More Location
UAB Comprehensive Cancer Center
Learn More & Join Trial
Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML PHASE1 Acute myeloid leukemia (AML) is a clonal disease caused by genetic mutation...
Show More Learn More & Join Trial
Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia PHASE1 This phase I/II trial studies the side effects and best dose of dasatinib w...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies combination chemotherapy with blina...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) PHASE1 An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Show More Location
Childrens Hospital Los Angeles
Learn More & Join Trial
A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer PHASE2 Patients with histologically or cytologically confirmed metastatic colorect...
Show More Location
Aberdeen Royal Infirmary, Foresterhill,
Learn More & Join Trial
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) PHASE1 This pilot clinical trial studies the side effects of pegaspargase when giv...
Show More Location
Phoenix Childrens Hospital
Learn More & Join Trial